APA aipamena

Shirakura, T., Nomura, J., Matsui, C., Kobayashi, T., Tamura, M., & Masuzaki, H. (2016). Febuxostat, a novel xanthine oxidoreductase inhibitor, improves hypertension and endothelial dysfunction in spontaneously hypertensive rats. Naunyn Schmiedebergs Arch Pharmacol.

Chicago Style aipamena

Shirakura, Takashi, Johji Nomura, Chieko Matsui, Tsunefumi Kobayashi, Mizuho Tamura, and Hiroaki Masuzaki. "Febuxostat, a Novel Xanthine Oxidoreductase Inhibitor, Improves Hypertension and Endothelial Dysfunction in Spontaneously Hypertensive Rats." Naunyn Schmiedebergs Arch Pharmacol 2016.

MLA aipamena

Shirakura, Takashi, et al. "Febuxostat, a Novel Xanthine Oxidoreductase Inhibitor, Improves Hypertension and Endothelial Dysfunction in Spontaneously Hypertensive Rats." Naunyn Schmiedebergs Arch Pharmacol 2016.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.